Journal of Pediatric and Adolescent Gynecology
Volume 22, Issue 3 , Pages e1-e3 , June 2009

Treatment of Premenstrual Syndrome with the Desogestrel-only Pill (Cerazette) in an Adolescent Girl

  • Catherine Georgantopoulou, MRCOG, MFFP

      Affiliations

    • Evgenideion Hospital Athens, Greece
    • Corresponding Author InformationAddress correspondence to: Catherine Georgantopoulou, 7 Loukianou Street, Kolonaki, 10675, Athens, Greece
    • ,
  • Sue Field, MRCOG

      Affiliations

    • Gateshead, Great Britain

References 

  1. Magos AL, Studd JW: The premenstrual syndrome. In Studd JW (ed): Progress in obstetrics and gynecology, vol 4, Edinburgh, Churchill Livingstone, 1934, 334-350
  2. Vichnin M, Freeman EW, Lin H, et al. Premenstrual syndrome (PMS) in adolescents: severity and impairment. J Pediatr Adolesc Gynecol. 2006;19:397
  3. Ad hoc expert waiting on the safety of SSRIs. November 17, 2002; http://www.mhra.gov.uk/SearchHelp/searchresults/index.htm?within=yes&keywords=SSRIs. Accessed September 2007).
  4. Pabinger I, Schneider B. Thrombotic risk of women with hereditary antithrombin III, protein C- and protein S-deficiency taking oral contraceptive medication. The GTH Study on Natural Inhibitors. Thromb Haemost. 1994;71:548
  5. Vanderbroucke JP, Rosing J, Bloemenkamp KWM, et al. Oral contraceptives and the risk of venous thrombosis. N Engl J Med. 2001;344:1527
  6. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception: Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives. Results of an international, multicenter, case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Contraception. 1998;57:315
  7. Heinemann LA, Assman A, DoMinh T, et al. Oral progestogen-only contraceptives and cardiovascular risk: results from the Transnational Study on Oral Contraceptives and the Health of Young Women. Eur J Contracept Reprod Health Care. 1999;4:677
  8. Winkler UH, Howie H, Buchler K, et al. A randomized controlled double-blind study of the effects on hemostasis of two progestogen-only pills containing 75μg Desogestrel or 30μg Levonorgestrel. Contraception. 1998;57:385
  9. Organon Laboratories LimitedCerazette: Summary of Product Characteristics, 2005. Available: www.emc.medicines.org.uk. Accessed October 20, 2006

PII: S1083-3188(08)00180-0

doi: 10.1016/j.jpag.2008.04.009

Journal of Pediatric and Adolescent Gynecology
Volume 22, Issue 3 , Pages e1-e3 , June 2009

Article Tools